Susquehanna Fundamental Investments’s Q32 Bio QTTB Stock Holding History

Susquehanna Fundamental Investments’s Portfolio QTTB Stock Details QTTB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	$71K	Sell	1,303 -319	-20%	-$19.8K	﹤0.01%	1477
2021 Q4	$106K	Buy	1,622 +271	+20%	+$26.3K	﹤0.01%	1329
2021 Q3	$191K	Sell	1,351 -131	-9%	-$16.7K	﹤0.01%	1549
2021 Q2	$194K	Buy	1,482 +710	+92%	+$88.6K	﹤0.01%	1493
2021 Q1	$131K	Sell	772 -1,240	-62%	-$261K	﹤0.01%	1444
2020 Q4	$409K	Sell	2,012 -1,562	-44%	-$302K	0.01%	1170
2020 Q3	$688K	Buy	3,574 +1,496	+72%	+$335K	0.02%	770
2020 Q2	$568K	Buy	+2,078	New	+$554K	0.03%	583

Other funds holding QTTB

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

5VM

5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VVA

Vida Ventures Advisors Boston, Massachusetts $29.4M AUM 93.58% 1-Year Est. Return

Susquehanna Fundamental Investments's QTTB Position: Q1 2022 in Review

Susquehanna Fundamental Investments reduced its Q32 Bio (QTTB) stake by 20% in Q1 2022, selling an estimated $19.8K and leaving 1,303 shares worth $71K. The position accounts for ﹤0.01% of the portfolio, ranked #1477.

Susquehanna Fundamental Investments first reported a position in QTTB in Q2 2020 and has held it in 8 quarters since. The position peaked at $688K in Q3 2020. 106 funds tracked by Wall St. Rank hold QTTB as of Q1 2022.

Susquehanna Fundamental Investments held 1,303 shares of Q32 Bio worth $71K as of Q1 2022.
Susquehanna Fundamental Investments sold 319 Q32 Bio shares in Q1 2022, an estimated $19.8K.
Q32 Bio made up ﹤0.01% of Susquehanna Fundamental Investments's portfolio in Q1 2022, its #1477 holding.
Susquehanna Fundamental Investments first reported a position in Q32 Bio in Q2 2020 and has held it in 8 quarters since.
Susquehanna Fundamental Investments's Q32 Bio position peaked at $688K in Q3 2020.
106 funds tracked by Wall St. Rank held Q32 Bio as of Q1 2022.

Based on Susquehanna Fundamental Investments's 13F filing for Q1 2022, filed 16 May 2022.